Highlights
- NIB Holdings is an ASX-listed private health insurer with client base in New Zealand and Australia
- In FY23, the company registered 10.9% YoY growth in revenue to AUD 3.1 billion
- The Vanguard Group, Inc. has the highest stake in NHF with a shareholding of around 4.99%
NIB Holdings Limited (ASX: NHF) is an ASX-listed firm which offers medical and insurance to New Zealand and Australian residents. Also, the health insurance services provider offers its services to international workers and students in Australia. The New South Wales based company operates through multiple segments including Australian Residents Health Insurance (arhi), International Inbound Health Insurance (iihi), New Zealand (nib NZ), nib Thrive, and nib Travel.
The 3.66 billion market cap firm witnessed a 10.9% YoY increase in revenue to AUD 3.1 billion during the financial year 2023 (FY23). During the stated period, underlying operating profit grew by 11.1% YoY to AUD 263.2 million, net profit after tax increased by 42.8% YoY and dividend grew by 27.3% annually.
In FY23, arhi business of NHF delivered highest sales and net policyholder growth in over eight years.
Top 10 shareholders of NHF
The top 10 shareholders of NHF have around15.28% shareholding in the firm, while the top four have nearly 9.73% shareholding. The Vanguard Group, Inc. and Vanguard Investments Australia Ltd. Have the maximum stake in the firm with a shareholding of ~4.99% and ~1.73%, respectively.

Recent business update
Through an ASX update dated 13 December 2023, the company shared that it’s director, Jill Watts has acquired 3,154 shares in the firm. Watts Super Fund a/c acquired these shares for AUD 23,497.30 on 8 December 2023.
On 10 November 2023, the company shared a trading update for the four months of FY24, ending on 31 October 2023. During the reported period, the company delivered a 13.2% YoY increase in revenue, excluding Qantas. The period witnessed increase in policyholders and premium revenue from arhi, iihi and New Zealand segments. However, a decline was seen in sales and operating income from nib Travel.
Outlook
The company expects to see continuous growth in its private health insurance business across New Zealand and Australia. In FY24, the company anticipates 3-4% growth in arhi net policyholder and 3-4% growth in New Zealand net residents PHI policyholder base.
Profitability is expected to improve for nib travel and rebound in student policyholders is expected in iihi, along with growth and strength in workers policies.
The company is committed to deliver seamless and personalized digital-first health experience.
Share performance of NHF
Shares of NHF closed 0.4% down at AUD 7.53 apiece on 8 January 2024. With this, NHF’s share price has fallen by 2.08% in the last 12 months and has decreased by 11.72% in the last six months.
The 52-week high of NHF is AUD 8.95, recorded on 21 June 2023, and the 52-week low is AUD 6.74, recorded on 20 March 2023.

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.
Note 2: The reference date for all price data, and currency, is 8 January 2023. The reference data in this report has been partly sourced from REFINITIV.
Disclaimer:
This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.
Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.
Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.
The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.
The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.
Kalkine does not issue, sell or deal in any financial products.
This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.
To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Article, or its content, may be reproduced in any form without our prior consent.